SYNLOGIC, INC.

Synlogic, Inc.

Biotechnology Healthcare Winchester, MA, United States SYBX (NCM)

Synlogic, Inc., a biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618 for the treatment of phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and Ginkgo Bioworks, Inc. Synlogic, Inc. is based in Winchester, Massachusetts.

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Biotechnology Companies

View All →

Frequently Asked Questions

Has SYNLOGIC, INC. had layoffs?
No layoff events have been recorded for SYNLOGIC, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does SYNLOGIC, INC. have?
SYNLOGIC, INC. has approximately 1 employees.
What industry is SYNLOGIC, INC. in?
SYNLOGIC, INC. operates in the Biotechnology industry, within the Healthcare sector.
Is SYNLOGIC, INC. a publicly traded company?
Yes, SYNLOGIC, INC. is publicly traded under the ticker symbol SYBX on the NCM. The company has a market capitalization of approximately $0.01 billion.
Where is SYNLOGIC, INC. headquartered?
SYNLOGIC, INC. is headquartered in Winchester, MA, United States at PO Box 30, Winchester, MA 01890, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.